PF-3446879

N/A

Report date: 2022/02/21 13:36:57

Base Information

Drug NamePF-3446879

Drug Alias NameMyostatin targeted monoclonal antibody (Pfizer)PF-3446879

ClassificationBiologics

Mechanisms of ActionGrowth/differentiation factor 8 inhibitors

TargetsGrowth/differentiation factor 8

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsCardiovascular Diseases

ATC CodeN/A